James Investment Research’s PetMed Express PETS Stock Holding History

James Investment Research’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,712	Closed	-$296K	–	626
2022 Q4	$296K	Sell	16,712 -13,466	-45%	-$267K	0.04%	227
2022 Q3	$589K	Hold	30,178	–	–	0.08%	167
2022 Q2	$601K	Buy	30,178 +6,919	+30%	+$155K	0.08%	165
2022 Q1	$600K	Buy	23,259 +7,559	+48%	+$196K	0.06%	188
2021 Q4	$397K	Buy	15,700 +5,700	+57%	+$158K	0.04%	224
2021 Q3	$269K	Sell	10,000 -4,100	-29%	-$118K	0.03%	246
2021 Q2	$449K	Buy	14,100 +3,900	+38%	+$124K	0.04%	221
2021 Q1	$359K	Sell	10,200 -10,250	-50%	-$357K	0.03%	230
2020 Q4	$656K	Buy	+20,450	New	+$630K	0.06%	184
2017 Q1	–	Sell	-119,365	Closed	-$2.75M	–	691
2016 Q4	$2.75M	Buy	119,365 +29,530	+33%	+$633K	0.07%	199
2016 Q3	$1.82M	Buy	+89,835	New	+$1.81M	0.05%	206

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

James Investment Research's PETS Position: Q1 2023 in Review

James Investment Research sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 16,712 shares — an estimated $296K sold.

James Investment Research first reported a position in PETS in Q3 2016 and held it in 11 quarters. The position peaked at $2.75M in Q4 2016. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

James Investment Research reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
James Investment Research sold 16,712 PetMed Express shares in Q1 2023, an estimated $296K.
James Investment Research first reported a position in PetMed Express in Q3 2016 and held it in 11 quarters.
James Investment Research's PetMed Express position peaked at $2.75M in Q4 2016.
165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on James Investment Research's 13F filing for Q1 2023, filed 26 Apr 2023.